Orrick Advises capAI on R42 Group Alliance

Orrick Advises capAI on Strategic Alliance with R42 Group

Orrick, a leading international law firm, advised capAI plc, an AI innovation business listed on the London Stock Exchange Main Market, on its strategic Alliance with R42 Group, LLC, a venture capital firm based in Palo Alto, California. This Alliance, effective June 1, 2025, aims to enhance capAI's operating model through a transatlantic platform, focusing on early-stage AI opportunities in media and medicine.

The Alliance is designed to leverage R42 Group's extensive network and infrastructure, enabling capAI to access high-quality AI innovations with capital efficiency. This partnership positions capAI to pursue breakthrough opportunities in the AI landscape, particularly in the media and medicine sectors, while maintaining strategic flexibility.

Enhancing AI Innovation through Transatlantic Collaboration

The transatlantic platform established through this Alliance will facilitate the sourcing, development, and commercialization of early-stage AI technologies. By combining capAI's expertise in AI with R42 Group's venture-building capabilities, the partnership aims to accelerate the growth of innovative AI solutions in media and medicine. This collaboration reflects a shared commitment to capital-efficient innovation and the pursuit of high-growth AI opportunities.

Richard Edwards, Executive Chairman of capAI, highlighted the significance of the Alliance, stating, "This partnership with R42 Group is a major step in executing our refined operating strategy. It establishes a transatlantic innovation platform that combines AI expertise, capital efficiency, and public market access. The projects under review demonstrate our commitment to AI solutions in media and medicine, aligning with our vision of AI-empowered value creation.">

Leveraging Expertise and Resources for AI Breakthroughs

Professor Ronjon Nag, Founder of R42 Group, emphasized the potential of the Alliance to create an innovation pipeline. "By combining R42's venture-building expertise with capAI's public market access, we can accelerate the commercialization of breakthrough technologies," he said. "This partnership reflects our shared commitment to capital-efficient innovation and the pursuit of AI opportunities in media and medicine.">

The Orrick team, led by Ed Dyson, played a crucial role in advising capAI on this strategic Alliance. The team included Faraaz Samadi, Rebecca Servian, Michael Wiesner, Shannon Yavorsky, Abigail Parkin, Charles Sheldon, and James Labovitch, who provided comprehensive legal support throughout the process.

Future Implications and Strategic Flexibility

The Alliance between capAI and R42 Group is expected to drive significant advancements in AI innovation, particularly in media and medicine. By leveraging the strengths of both companies, the partnership aims to identify, incubate, and invent AI solutions that address critical challenges in these sectors. The strategic flexibility of the Alliance will allow capAI to explore high-growth opportunities across the broader AI landscape, ensuring sustained innovation and market leadership.